Baxil Pharma Private Limited, a active private limited company, was established on 28 December 2005 in East Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2005PTC144166. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Baviera Pharmaceuticals Private Limited. It upholds a compliant status. Employing 17 professional, Its leadership includes Virendra Kumar Sharma (Additional Director), Anil Singh (Director), Asha Singh (Director). Past directors included Swati Singh, Anil Singh. It holds ₹9.00 M open charges and ₹4.50 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Village Chilla, Saronda Bangar In The Abadi Of Block-B, New Ashok Nagar, Illaqa Shahdara, East Delhi, Delhi, 110096.
U24232DL2005PTC144166
144166
28 December 2005
₹3.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Baxil Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Virendra Kumar Sharma | Additional Director | 21 Dec 2023 | Current |
| Anil Singh | Director | 17 Jan 2014 | Current |
| Asha Singh | Director | 28 Dec 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Apr 2016 | Past |
| Pramod Abcsdd | Director | 22 Nov 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Baxil Pharma Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 5.47% decrease. The company also saw a substantial improvement in profitability, with a 974.97% increase in profit. The company's net worth moved up by a moderate rise of 1.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Baxil Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹9,000,000.00
₹45,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jul 2010 | Others | ₹9.00 M | Open |
| 11 Jul 2007 | Punjab National Bank | ₹2.50 Cr | Satisfied |
| 11 Jul 2007 | Punjab National Bank | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Baxil Pharma has a workforce of 17 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Baxil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baxil Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Baxil Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Baxil Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Progress on A charge with Others of Rs. 0.90 Cr registered on 14 Jul 2010 with Charge ID 10237147 was modified on 29 Apr 2024. was documented.
A charge registered on 11 Jul 2007 via Charge ID 10061843 with Punjab National Bank was fully satisfied on 24 Apr 2024. was recorded as a recent event.
Progress on Virendra Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 21 Dec 2023 & has been associated with this company since 1 year 11 months . was documented.
A charge registered on 11 Jul 2007 via Charge ID 10061838 with Punjab National Bank was fully satisfied on 23 Jan 2020. was recorded as a recent event.
The CIN of Baxil Pharma Private Limited is U24232DL2005PTC144166.
Baxil Pharma Private Limited is headquartered at Village Chilla, Saronda Bangar In The Abadi Of Block-B, New Ashok Nagar, Illaqa Shahdara, East Delhi, Delhi, 110096.
Baxil Pharma Private Limited was incorporated on 28 December 2005.
The current directors of Baxil Pharma Private Limited are
The primary industry of Baxil Pharma Private Limited is Manufacturing.
Baxil Pharma Private Limited is unlisted.
The authorized capital of Baxil Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Baxil Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX